Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Daxor Announces Largest Sale of the BVA-100 Blood Volume Analyzer to Single User Group.


Business/Health Editors

NEW YORK--(BW HEALTHWIRE)--March 10, 2000

The Daxor Corporation has signed an agreement with Newman Associates, a private medical group, for the purchase of 10 BVA-100 Blood Volume Analyzers and the rental of an eleventh unit. The units will be used for outpatient blood volume measurements in Imaging Centers and other specialized facilities. Abnormalities in blood volume are common in many disease conditions. Congestive heart failure congestive heart failure, inability of the heart to expel sufficient blood to keep pace with the metabolic demands of the body. In the healthy individual the heart can tolerate large increases of workload for a considerable length of time.  is the number one cause for admission to US hospitals. Approximately $38 billion is spent annually on treatments for congestive heart failure, of which $23 billion is spent on in-hospital treatments. Blood volume expansion is a common problem in congestive heart failure. There are multiple complex therapies to treat this condition, however, treatment has rarely included measurement of blood volume because of the difficulty in obtaining this test. A recent article in the January issue of the Journal of the American College of Cardiology The American College of Cardiology (ACC) is a nonprofit medical association established in 1949 to educate, research and influence health care public policy. The president for the 2006–2007 year is Steven E. Nissen. [1] The organization has 39 chapters in the U.S.  reported that a significant percentage of patients with congestive heart failure may be treated to the point where they have low blood volume and decompensation decompensation /de·com·pen·sa·tion/ (de?kom-pen-sa´shun)
1. inability of the heart to maintain adequate circulation, marked by dyspnea, venous engorgement, and edema.

2.
 from their treatment. The use of accurate blood volume measurement offers the possibility of a more scientific specific therapy which may enable patients to avoid unnecessary hospitalization.

There are approximately 50 million patients who have hypertension (high blood pressure) in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. . The March 2000 issue of the Mayo clinic Mayo Clinic: see Mayo, Charles Horace.

Mayo Clinic

voluntary association of more than 500 physicians in Rochester, Minnesota. [Am. Hist.: EB, 11: 723]

See : Medicine
 reports that over 70% of hypertensive hypertensive /hy·per·ten·sive/ (-ten´siv)
1. characterized by increased tension or pressure.

2. an agent that causes hypertension.

3. a person with hypertension.
 patients are resistant to their treatment and are not optimally treated. They reported in a study that the measurement of plasma volume, which is part of a blood volume measurement, improved their ability to treat their hypertensive patients.

The BVA-100 provides a rapid and the most accurate system for measurement of both blood and plasma volume available today. Blood volumes have traditionally been difficult to perform and time consuming. A major problem has been obtaining an accurate norm for a specific individual. The BVA-100 Blood Volume Analyzer provides rapid calculation of normal blood volume for specific individuals that has previously not been available. Blood volume measurements are useful in conditions ranging from hemorrhage to septic (toxic) shock. The company has received preliminary information from a hospital using the BVA-100 in treatment of septic shock Septic Shock Definition

Septic shock is a potentially lethal drop in blood pressure due to the presence of bacteria in the blood.
Description

Septic shock is a possible consequence of bacteremia, or bacteria in the bloodstream.
 patients. They found that blood volume measurements used for treatment provided critical information, which helped to lower the mortality rate in patients with septic shock. The results from this hospital will be reported at a future time.

Blood volume derangement's are common in many medical and surgical conditions. The availability of a rapid accurate method for measuring blood volume can be expected to improve patient outcomes with these problems. Additional information can be found on the website www.Daxor.com.

For further information, contact Fatima S. Baha, Investor Relations Investor relations

The process by which the corporation communicates with its investors.
 or Joseph Feldschuh, M.D., President & CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. .
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Mar 10, 2000
Words:466
Previous Article:REPEATING/FreeMarkets Selects Micromuse's NETCOOL Software For Real-Time Monitoring of Web-Based B2B Emarketplace.
Next Article:Alan Spoon to Leave the Washington Post Company and Join Polaris Venture Partners.
Topics:



Related Articles
Daxor Corporation to Nominate Bruce Slovin to Board of Director At Annual Meeting in June 2002.
Daxor Corporation Announces the Formation of Daxor Capital; New Division Will Provide Equipment Financing for BVA-100.
Daxor Corporation Signs Agreement with Washington Hospital Center for BVA-100.
Daxor Corporation Announces the Purchase of a BVA-100 by Two Regional Medical Centers.
Daxor Corporation Announces Children's Hospital Medical Center of Akron to Obtain a BVA-100 for Burn Unit.
Daxor Corporation -AMEX: DXR- Announces Third Quarter Earnings 2003.
Daxor Corporation Receives Signed Agreement from University Hospitals of Cleveland.
Daxor Corporation Announces First Quarter 2005 Earnings.
Daxor Announces the Receipt of a Signed Agreement from the Carolinas Medical Center, Charlotte, North Carolina.
Daxor Announces Carolinas Medical Center of Charlotte, NC Purchases BVA-100 and Blood Volume Kit Usage Increases 40%.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles